Exosomes: A role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment

Current Gene Therapy

Volumn 15, Issue 2, 2015, Pages 182-192

  Srivastava, Akhil ^a,b   Filant, Justyna ^c   Moxley, Katherine M ^a,b   Sood, Anil ^c   McMeekin, Scott ^a,b   Ramesh, Rajagopal ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biomarkers; Cancer; Exosomes; Gene therapy; miRNA; siRNA

Indexed keywords

CALNEXIN; DNA; EPHRIN RECEPTOR A2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUCOSE REGULATED PROTEIN 94; LIPID; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEIC ACID; PROTEIN; STAT3 PROTEIN; TETRASPANIN;

ARTICLE; BIOGENESIS; CANCER GROWTH; CELL COMMUNICATION; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; DISEASE COURSE; ELECTROPORATION; EXOSOME; FLOW CYTOMETRY; GENE SILENCING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MULTIVESICULAR BODY; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; SURFACE PLASMON RESONANCE; SURVIVAL RATE; TRANSMISSION ELECTRON MICROSCOPY; WNT SIGNALING PATHWAY; BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; GENE THERAPY; GENETICS; NEOPLASMS;

BLOOD-BRAIN BARRIER; CELL COMMUNICATION; DRUG DELIVERY SYSTEMS; EXOSOMES; GENETIC THERAPY; HUMANS; MICRORNAS; NEOPLASMS; RNA, MESSENGER;

EID: 84941261402     PISSN: 15665232     EISSN: 18755631     Source Type: Journal    
DOI: 10.2174/1566523214666141224100612     Document Type: Article

References (82)

1. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. Garland Science: New York. General Principles of Cell Communication. Available from: http://www.ncbi.nlm.nih.gov/books/NBK26813/
2. Bobrie A, Colombo M, Raposo, G, Thery C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 2011; 12:1659-68.
3. Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retroviruslike vesicles, and apoptotic bodies. J Neurooncol 2013; 113:1-11.
4. Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 2013; 200:373-83.
5. Hristov M, Erl W, Linder S, Weber PC. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 2004; 104:2761-66.
6. O’Loughlin AJ1, Woffindale CA, Wood MJ. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther 2012; 12:262-74.
7. Sybalska EH, Szybalski W. Genetics of human cell line, IV. DNAmediated heritable transformation of a biochemical trait. Proc Natl Acad Sci USA 1962; 48:2026-34.
8. Collet G, Grillon C, Nadim M, Kieda C. Trojan horse at cellular level for tumor gene therapies. Gene 2013; 525:208-16.
9. Thery C, Zitvogel L, Amigorena, S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2:569-79.
10. Koles K, Budnik V. Exosomes go with the Wnt. Cell Logist 2012; 2:169-73.
11. Marimpietri D, Petretto A, Raffaghello L, et al. Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS ONE 2013; 8:e75054.
12. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-9.
13. Adamcik J, Klinov DV, Witz G, Sekatskii SK, Dietler G. Observation of single-stranded DNA on mica and highly oriented pyrolytic graphite by atomic force microscopy. FEBS Lett 2006; 580:5671-5.
14. Kahlert C, Melo SA, Protopopov A, et al. Identification of doublestranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 2014; 289:3869-75.
15. Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 2014; 24:766-9.
16. Johnstone RM, Adam M, Pan BT. The fate of the transferrin receptor during maturation of sheep reticulocytes in vitro. Can J Biochem Cell Biol 1984; 62:1246-54.
17. Yang C, Robbins PD. Roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011; 2011:842-9.
18. Raiborg C, Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009; 458:445-52.
19. Wollert T, Hurley JH. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 2010; 464:864-9.
20. Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008; 319:1244-7.
21. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285:17442-52.
22. Johnsen KB, Gudbergsson MB, Skov MN, Pilgaard L, Moos T, Duroux M A Comprehensive overview of exosomes as drug delivery vehicles-endogenous nanocarriers for targeted cancer therapy. Biochim Biophys Acta 2014; 1846:75-87.
23. Hannafon BN, Ding WQ. Intercellular communication by exosome-derived microRNAs in Cancer. Int J Mol Sci 2013; 14:14240-69.
24. Mears R1, Craven RA, Hanrahan S, et al. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 2004; 4:4019-31.
25. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; 3:1-29.
26. Simpson RJ, Kalra H, Mathivanan S. ExoCarta as a resource for exosomal research. J Extracell Vesicles 2012; 1:1-6.
27. Tadokoro H, Umezu T, Ohyashiki K, Hirano T, Ohyashiki JH. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem 2013; 288:34343-51.
28. Dutta S, Warshall C, Bandyopadhyay C, Dutta D, Chandran B. Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS ONE 2014; 9:e97580.
29. Schageman J, Zeringer E, Li M, et al. The complete exosome workflow solution: from isolation to characterization of RNA cargo. Biomed Res Int 2013; 2013:253957.
30. Vojtech L, Woo S, Hughes S, et al. Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions. Nucleic Acids Res 2014;42:7290-304
31. Qazi KR, Torregrosa Paredes P, Dahlberg B, et al. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax 2010; 65:1016-24.
32. Fang DY, King HW, Li JY, Gleadle JM. Exosomes and the kidney: blaming the messenger. Nephrology (Carlton) 2013; 18:1-10.
33. Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 2012; 83:1484-94.
34. Masyuk AI, Masyuk TV, Larusso NF. Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol 2013; 59:621-25.
35. Riches A, Campbell E, Borger E, Powis S. Regulation of exosome release from mammary epithelial and breast cancer cells-a new regulatory pathway. Eur J Cancer 2014; 50:1025-34.
36. Gercel-Taylor C, Atay S, Tullis RH, Kesimer M, Taylor DD. Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. Anal Biochem 2012; 428:44-53.
37. Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic Tlymphocyte responses and anti tumour immunity. Immunology 2007; 120:90-102.
38. Kosaka N, Iguchi H, Hagiwara K, Yoshioka, Takeshita F, Ochiya T. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 2013; 288:10849-59.
39. Peinado H, Alečković M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18:883-91.
40. Huber V, Fais S, Iero M, et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005; 128(7):1796-804.
41. Valenti R, Huber V, Filipazzi P, et al. Human tumor released microvesicles promote the differentiation of myeloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes. Cancer Res 2006; 66:9290-8.
42. Liu C, Yu S, Zinn K, et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006; 176:1375-85.
43. Chalmin F, Ladoire S, Mignot G, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest 2010; 120:457-71
44. Xiao X, Yu S, Li S, et al. Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin. PLoS ONE 2014; 9(2):e89534
45. Safaei R, Larson BJ, Cheng T, et al. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 2005; 4 (10):1595-604.
46. Ciravolo V, Huber V, Ghedini GC, et al. Potential role of HER2-overexpressing exosomes in countering Trastuzumab basedtherapy. J Cell Physiol 2012; 227:658-67.
47. Regev-Rudzki N, Wilson DW, Carvalho TG, et al. Cell-cell communication between malaria-infected red blood cells via exosomelike vesicles. Cell 2013; 153:1120-33.
48. Singh PP, LeMaire C, Tan JC, Zeng E, Schorey JS. Exosomes released from M. tuberculosis infected cells can suppress IFN-γ mediated activation of naive macrophages. PLoS ONE 2011; 6:e18564.
49. Barutta F, Tricarico M, Corbelli A, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS ONE 2013; 8:e73798.
50. Lv LL, Cao YH, Pan MM, et al. CD2AP mRNA in urinary exosome as biomarker of kidney disease. Clin Chim Acta 2014; 428:26-31.
51. van Balkom BW, Pisitkun T, Verhaar MC, Knepper MA. Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int 2011; 80:1138-45.
52. van Empel VP, De Windt LJ, da Costa Martins PA. Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens Rep 2012; 14:498-509.
53. Gupta A, Pulliam L. Exosomes as mediators of neuroinflammation. J Neuroinflammation 2014; 11:68.
54. Suetsugu A, Honma K, Saji S, Moriwaki H, Ochiya T, Hoffman RM. Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv Drug Deliv Rev 2013; 65:383-90.
55. van der Meel R, Krawczyk-Durka M, van Solinge WW, Schiffelers RM. Toward routine detection of extracellular vesicles in clinical samples. Int J Lab Hematol 2014; 36:244-53.
56. Franzen CA, Simms PE, Van Huis AF, Foreman KE, Kuo PC, Gupta GN. Characterization of uptake and internalization of exosomes by bladder cancer cells. Biomed Res Int 2014; 2014:619829.
57. Im H, Shao H, Park YI, et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol 2014; 32:490-95.
58. Yoshioka Y, Kosaka N, Konishi Y, et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun 2014; 5:3591.
59. Kanwar SS, Dunlay CJ, Simeone DM, et al. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip 2014; 14(11):1891-900.
60. Zhu L1, Wang K, Cui J. Label-free quantitative detection of tumorderived exosomes through surface plasmon resonance imaging. Anal Chem 2014; 86(17):8857-64.
61. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumorderived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008; 110:13-21.
62. Kooijmans SA, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM. Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine 2012; 7:1525-41.
63. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011; 29:341-5.
64. El Andaloussi S, Lakhal S, Mager I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 2013; 65:391-7.
65. Shtam TA, Kovalev RA, Varfolomeeva EY, Makarov EM, Kil YV, Filatov MV. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal 2013; 11:88.
66. Pan Q, Ramakrishnaiah V, Henry S, et al. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut 2012 Sep; 61:1330-9.
67. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97.
68. Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol 2012; 6:590-610.
69. Nishimura M, Jung EJ, Shah MY, et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov 2013;3(11):1302-15.
70. Roush S, Slack FJ. The Let-7 family of micro RNAs. Trends Cell Biol 2008; 18: 505-16.
71. Ohshima K, Inoue K, Fujiwara A, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS ONE 2010; 5:e13247.
72. Kogure T, Lin WL, Yan IK, Braconi C, Patel T. Intercellular nanovesicle mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011; 54:1237-48.
73. Wahlgren J, Karlson TDL, Brisslert M, et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 2012; 40:e130.
74. Hood JL, Scott MJ, Wickline SA. Maximizing exosome colloidal stability following electroporation. Anal Biochem 2014; 448:41-9.
75. Kooijmans SA, Stremersch S, Braeckmans K, et al. Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. J Control Release 2013; 172:229-38.
76. Meckes DG Jr, Raab-Traub N. Microvesicles and viral infection. J Virol 201; 85:12844-54.
77. Hessvik NP, Phuyal S, Brech A, Sandvig K, Llorente A. Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Bio Chim Biophys Acta 2012; 1819:1154-63.
78. Olga Vaksman O, Trope C, Davidson B, Reich R. Exosomederived miRNAs and ovarian carcinoma progression. Carcinogen 2014; 5(9):2113-20.
79. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009;10: 42-6.
80. Tickner JA, Urquhart AJ, Stephenson SA, Richard DJ, O’Byrne KJ. Functions and Therapeutic Roles of Exosomes in Cancer. Front Oncol 2014; 27:127.
81. Ji H, Greening DW, Barnes TW et al. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 2013; 13:1672-86.
82. Rosell R, Wei J, Taron M. Circulating microRNA signatures of tumor-derived exosomes for early diagnosis of non-small-cell lung cancer. Clin Lung Cancer 2009; 10:8-9.